MIGLIETTA, FEDERICA

MIGLIETTA, FEDERICA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.047 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Serie Titolo libro
Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all? 2017 MIGLIETTA, FEDERICADieci, M. V.GRIGUOLO, GAIAGUARNERI, VALENTINACONTE, PIERFRANCO CANCER TREATMENT REVIEWS - -
External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience 2018 Griguolo, GaiaDieci, MARIA VITTORIAMiglietta, FedericaConte, PierfrancoGuarneri, Valentina + THE BREAST - -
Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary 2018 Miglietta, FedericaTsvetkova, VassilenaDieci, Maria VGuarneri, Valentina + FRONTIERS IN ONCOLOGY - -
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer 2018 Griguolo, GaiaDieci, Maria VittoriaMiglietta, FedericaConte, Pier. Franco.Guarneri, Valentina + JOURNAL OF NEURO-ONCOLOGY - -
Immune characterization of breast cancer metastases: Prognostic implications 2018 Dieci, Maria VittoriaTSVETKOVA, VASSILENAGriguolo, GaiaMiglietta, FedericaCappellesso, RoccoVernaci, GraziaTasca, GiuliaConte, PierfrancoGuarneri, Valentina + BREAST CANCER RESEARCH - -
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology 2018 Griguolo, GaiaDieci, Maria VittoriaMiglietta, FedericaConte, PierfrancoGuarneri, Valentina + THE ONCOLOGIST - -
BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis 2019 Vernaci G.Dieci M. V.MANFRIN, SILVIAMantiero M.Menichetti A.Griguolo G.Miglietta F.Di Liso E.Conte P.Guarneri V. + THE BREAST - -
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value 2019 Miglietta F.Griguolo G.Guarneri V.Dieci M. V. THE ONCOLOGIST - -
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives 2019 Miglietta, FedericaDieci, Maria Vittoria + CANCERS - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer 2019 Dieci, M VConte, PMiglietta, FGuarneri, V + ANNALS OF ONCOLOGY - -
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study 2019 Giarratano T.Frezzini S.Giorgi C. A.Mioranza E.Miglietta F.Griguolo G.Tasca G.Di Liso E.Vernaci G.Menichetti A.Mantiero M.Grosso D.Guarneri V.Dieci M. V. + THE BREAST JOURNAL - -
Neoplastic Pericardial Effusion: A Monocentric Retrospective Study 2019 MENICHETTI, ALICEDieci M. V.PADOVAN, MARTANAPPO, FLORIANACUMERLATO, ENRICOMiglietta F.Guarneri V.Conte P. + JOURNAL OF PALLIATIVE MEDICINE - -
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 2020 Miglietta F.Dieci M. V.Tsvetkova V.Griguolo G.Vernaci G.Menichetti A.Faggioni G.Giarratano T.Mioranza E.Genovesi E.Cumerlato E.Bottosso M.Conte P.Guarneri V. + THE ONCOLOGIST - -
Olaparib for advanced breast cancer 2020 Griguolo G.Dieci M. V.Miglietta F.Guarneri V.Conte P. FUTURE ONCOLOGY - -
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy 2020 Dieci M. V.Tsvetkova V.Griguolo G.Miglietta F.Tasca G.Giorgi C. A.Cumerlato E.Massa D.Orvieto E.Guarneri V.Conte P. + EUROPEAN JOURNAL OF CANCER - -
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors 2020 Dieci M. V.Miglietta F.Griguolo G.Guarneri V. CANCER TREATMENT REVIEWS - -
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 2020 Guarneri, ValentinaGriguolo, GaiaDieci, Maria VUrso, LoredanaMiglietta, FedericaConte, Pierfranco + THE LANCET ONCOLOGY - -
Therapeutic strategies for the management of hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) breast cancer: A review of the current literature 2020 Miglietta F.Guarneri V. + CANCERS - -
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 2020 Di Liso, ElisabettaBottosso, MicheleTsvetkova, VassilenaDieci, Maria VittoriaMiglietta, FedericaTasca, GiuliaGiorgi, Carlo AlbertoGiarratano, TommasoMioranza, EleonoraDei Tos, Angelo PaoloConte, PierFrancoGuarneri, Valentina + ESMO OPEN - -